Join
Live feed
·
INSIDERFilingvia Quantisnow
C4 Therapeutics Inc. logo

Chief Scientific Officer Mahaney Paige was granted 76,800 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CCCC· C4 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CCCC (C4 Therapeutics Inc.) and more on Quantisnow.

Chief Scientific Officer Mahaney Paige was granted 76,800 shares (SEC Form 4) | Quantisnow